U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492043) titled 'Breast Tumour Size Measurement by Field Cycling Imaging' on March 19.
Brief Summary: The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately estimate tumour size in patients with a type of breast cancer called ductal carcinoma in situ (DCIS). The main question it aims to answer is:
Can FCI accurately estimate DCIS lesion size compared with histology results?
Participants will have a standard MRI scan and an FCI scan before undergoing surgery to remove the tumour.
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Ductal Carcinoma In Situ...